Pilot clinical bacteriology in the EVD care response to detect intercurring bloodstream infections and inform about appropriate antibiotic treatment
Project overview
The study explores the potential contribution of bacterial co-infections to case fatalities in Ebola Treatment Centres (ETCs).
Project solution
This project offers [specific solution or intervention] to tackle [challenge]. By implementing [strategies, tools, or innovations], the project aims to achieve [desired outcomes]. The approach is designed to [specific actions or methods] to bring about meaningful change in [community, region, or issue area].
Expected outcomes
This project aims to achieve [specific outcomes], such as [measurable results, improvements, or changes]. The expected impact includes [benefits to the target community, advancements in research or innovation, or long-term effects]. By the end of the project, we anticipate [specific changes or milestones] that will contribute to [broader goals or objectives].
Octavie Lunguya
Principal Investigator
We are firmly encouraged by the positive reactions of on-site clinicians and the DRC health authorities. In addition to clinical care, our findings will also contribute to understanding and preventing healthcare-associated infection in ETC-admitted patients, thereby also strengthening communities' confidence in the ETC care.
Jan Jacobs
Principal Investigator
Finding out if and how bacterial infections affect patients' course when at the Ebola Treatment Centers will improve individual patient care by early diagnosis and directed antibiotic treatment. In addition, the cumulative data will provide evidence to adapt empiric antibiotic treatment guidelines.
Principal Investigators: Jan Jacobs, ITM & Octavie Lunguya, INRB
Purpose
The study explores the potential contribution of bacterial co-infections to case fatalities in Ebola Treatment Centres (ETCs). Using blood culture expertise available through an ongoing surveillance project in DRC, the study will pilot clinical bacteriology tools (bacterial blood cultures, biomarkers) to study bacterial bloodstream infection in EVD patients.
Expected Outcomes
The study results will inform appropriate antibiotic treatment in an EVD setting and potentially improve patient outcomes. Results will contribute to the overall evidence base about hypothesised bacterial translocation in the gut as a cause of bloodstream infection in EVD patients; provide evidence about the occurrence of healthcare-acquired infections in ETC settings; and inform development of improved infection prevention and control measures. Results will be shared with clinicians involved in the current outbreak, informally organised under the leadership of WHO, Ministry of Health and INRB; and be used to amend (if needed) the current care guidelines.
Research Methodology (brief summary)
Observational study, collecting prospectively data from the pilot implementation of clinical bacteriology tools (bacterial blood cultures, biomarkers: C-Reactive Protein, Procalcitonin and white blood cell differential count, and early warning scores) as part of EVD care in the currently ongoing Ebola outbreak in N-Kivu and Ituri.
The laboratory work will be done in the EVD field laboratories run by INRB.
Project delivery & updates
Stay up to date with the latest developments from this project. Here, you will find details on what has been delivered, resources created, and regular updates as the project progresses. Access key documents, reports, and other materials to see how the project is making an impact.